908 Devices to Participate in Investor Conferences in March

BURLINGTON, Mass.--(BUSINESS WIRE)-- 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced it will participate in the following investor conferences.

• TD Cowen 46th Annual Healthcare Conference, Boston, MA
  Fireside chat on Wednesday, March 4 at 9:10 a.m. Eastern Time
  

• Leerink Global Healthcare Conference, Miami, FL
  Fireside chat on Monday, March 9 at 1:40 p.m. Eastern Time

Interested parties may access a live and archived webcast of these sessions on the “Investors” section of the company website at: www.908devices.com.

About 908 Devices
908 Devices is revolutionizing chemical analysis with its simple handheld devices, addressing life-altering applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers in vital health, safety and defense tech applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure, and global security threats. The Company designs and manufactures innovative products that bring together the power of complementary analytical technologies, software automation, and machine learning. For more information, visit www.908devices.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260224462797/en/

IR & Media
Barbara Russo
[email protected]

Source: 908 Devices

You May Also Be Interested In

• NOG Announces Proposed $500 Million Private Offering of Senior Notes
• We're Growing: Wolf Law, PLLC Expands Its Team to Better Serve Clients
• Preston Vawdrey Builds Modern Marketing Momentum for Growing SMBs